FIELD: pharmaceutical industry, in particular cyprofloxacine solution.
SUBSTANCE: claimed solution contains cyprofloxacine hydrochloride, sodium salt of ethylenediamine-N,N,N1,N1-tetraacetic acid, α-hydroxypropionic acid, sodium chloride, water for injections.
EFFECT: drug of increased biological availability without side effects.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS AND METHOD FOR THEIR OBTAINING | 2003 |
|
RU2248199C1 |
MEDICINAL AGENT ELICITING ANTIEMETIC EFFECT | 2002 |
|
RU2205634C1 |
PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
PREPARATION FOR TREATMENT OF COLIBACILLOSIS IN YOUNG AGRICULTURAL ANIMALS | 2007 |
|
RU2354353C1 |
LIQUID MEDICINAL FORM OF PIROXICAM | 1991 |
|
RU2062616C1 |
COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
ANTIBACTERIAL AGENT | 1988 |
|
RU1585944C |
LIVE VACCINE FOR PREVENTING INFLUENZA AND PREPARATION METHOD THEREOF | 2015 |
|
RU2604414C2 |
ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION FOR PARENTERAL USE IN SMALL DOSAGES VOLUME | 2014 |
|
RU2578433C1 |
AGENT FOR REDUCING PATHOLOGICAL CHANGES IN PROSTATIC HYPERPLASIA | 2020 |
|
RU2740946C1 |
Authors
Dates
2006-10-10—Published
2005-04-22—Filed